Eucommia, Cuscuta, and Drynaria Extracts Ameliorate Glucocorticoid-Induced Osteoporosis by Inhibiting Osteoclastogenesis Through PI3K/Akt Pathway

Efficacy of anti-osteoporotic medications in patients with rebound-associated fractures after denosumab discontinuation

(2021) Athanasios D. Anastasilakis et al.   JOURNAL OF CLINICAL DENSITOMETRY

Interleukin‑1 induces receptor activator of nuclear factor‑κB ligand‑independent osteoclast differentiation in RAW264.7 cells

(2021) Rongdong Liao et al.   Experimental and Therapeutic Medicine

RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling

(2020) Mohammad Tobeiha et al.   Biomed Research International

Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K‐AKT‐NFATc1 pathway

(2020) Jin Cui et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment

(2020) Pojchong Chotiyarnwong et al.   Nature Reviews Endocrinology

Ganoderma lucidum Immune Modulator Protein rLZ-8 Could Prevent and Reverse Bone Loss in Glucocorticoids-Induced Osteoporosis Rat Model

(2020) Yong Yang et al.   Frontiers in Pharmacology

3,5-dicaffeoyl‑epi-quinic acid from Atriplex gmelinii enhances the osteoblast differentiation of bone marrow-derived human mesenchymal stromal cells via WnT/BMP signaling and suppresses adipocyte differentiation via AMPK activation

(2020) Fatih Karadeniz et al.   PHYTOMEDICINE

Osteoblast-Osteoclast Communication and Bone Homeostasis

(2020) Jung-Min Kim et al.   Cells

Daphnetin ameliorates glucocorticoid-induced osteoporosis via activation of Wnt/GSK-3β/β-catenin signaling

(2020) Yongkui Wang et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Osteoporosis

(2019) Juliet E Compston et al.   LANCET

Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2

(2019) Toshihisa Komori   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Concise Review: Mesenchymal Stem Cells: From Roots to Boost

(2019) Anna Andrzejewska et al.   STEM CELLS

Idelalisib inhibits osteoclast differentiation and pre-osteoclast migration by blocking the PI3Kδ-Akt-c-Fos/NFATc1 signaling cascade

(2019) Jeong-Tae Yeon et al.   ARCHIVES OF PHARMACAL RESEARCH

Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis

(2019) Yanan An et al.   FASEB JOURNAL

Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis

(2019) Jianbo He et al.   Frontiers in Pharmacology

Runx2, an inducer of osteoblast and chondrocyte differentiation

(2018) Toshihisa Komori   HISTOCHEMISTRY AND CELL BIOLOGY

Tumor Necrosis Factor Alpha Promotes Osteoclast Formation Via PI3K/Akt Pathway-Mediated Blimp1 Expression Upregulation

(2017) LeCheng Wu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Osteoporosis treatment: recent developments and ongoing challenges

(2017) Sundeep Khosla et al.   Lancet Diabetes & Endocrinology

Chlorogenic Acid Prevents Osteoporosis by Shp2/PI3K/Akt Pathway in Ovariectomized Rats

(2017) Rong Ping Zhou et al.   PLoS One

Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?

(2016) Q Chen et al.   CELL DEATH AND DIFFERENTIATION

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

(2016) Robert A Adler et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Natural products for treatment of osteoporosis: The effects and mechanisms on promoting osteoblast-mediated bone formation

(2016) Jing An et al.   LIFE SCIENCES

Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression

(2015) Xiang-zhou Zeng et al.   ACTA PHARMACOLOGICA SINICA

Bromo-honaucin A inhibits osteoclastogenic differentiation in RAW 264.7 cells via Akt and ERK signaling pathways

(2015) Mahesh Sapkota et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The PI3K/AKT/mTOR interactive pathway

(2015) Tulin Ersahin et al.   Molecular BioSystems

miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway

(2015) Chenyang Zhao et al.   RNA Biology

Potential Antiosteoporotic Agents from Plants: A Comprehensive Review

(2013) Min Jia et al.   Evidence-based Complementary and Alternative Medicine

Ethanol Extracts of FreshDavallia formosana(WL1101) Inhibit Osteoclast Differentiation by Suppressing RANKL-Induced Nuclear Factor-κB Activation

(2013) Tzu-Hung Lin et al.   Evidence-based Complementary and Alternative Medicine

Osteoprotegerin influences the bone resorption activity of osteoclasts

(2013) YING-XIAO FU et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Glucocorticoid-induced osteoporosis: An update on effects and management

(2013) Bjoern Buehring et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pathophysiology of Osteoporosis

(2012) Laura A.G. Armas et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Akt Induces Osteoclast Differentiation through Regulating the GSK3 /NFATc1 Signaling Cascade

(2011) J. B. Moon et al.   JOURNAL OF IMMUNOLOGY

Denosumab: Anti-RANKL antibody

(2009) Paul D. Miller   Current Osteoporosis Reports

Functions of RANKL/RANK/OPG in bone modeling and remodeling

(2008) Brendan F. Boyce et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment

(2008) Kousuke Iba et al.   JOURNAL OF ORTHOPAEDIC SCIENCE